Beijing Konruns Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Beijing Kangchen Pharmaceutical Co., Ltd. (abbreviated as Kangchen Pharmaceutical) was founded in 2003 with the core mission of "using life sciences to care for human health". For 16 years, it has been committed to innovative drug research and development, highlighting new product features. It has now developed into a high-tech pharmaceutical enterprise that integrates research and development, production, and marketing. It was listed on the Shanghai Stock Exchange in August 2018, with stock code 603590. Since its establishment, Kangchen Pharmaceutical has remained steadfast in the development of new drugs: adhering to originality, highlighting new features, and pursuing excellence. The company currently has a listed national first class new drug - Suling. At the same time, we have multiple national first-class new drugs under research, including CX1026, CX1003, and KC1036, as well as 45 national and international invention patents. We have won multiple top honors in China, including the National 863 Program, the National Torch Program, and the Chinese Patent Excellence Award. As a local innovative drug research and development enterprise in China, Kangchen Pharmaceutical has accumulated rich experience in innovative drug research and development after more than ten years of practical experience in new drug development. From topic research, product screening, preclinical research, clinical research, registration and application, industrial transformation, to clinical re research after product launch... The company has established a complete research and development system and platform, and cultivated a mature and stable research and development team with international first-class level, It provides a strong and powerful guarantee for Kangchen Pharmaceutical's new drug creation and continuous success. |
| Headquarter | Beijing |
| Establish Date | 9/3/2003 |
| Listed Code | 603590.SH |
| Listed Date | 8/27/2018 |
| Chairman | Liu Jianhua. |
| CEO | Bull Battle Flag. |
| Website | www.konruns.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
